Wire
BlossomHill Therapeutics Shares Fall in Nasdaq Debut
BlossomHill Therapeutics (BLSM) shares fell 2.3% to $15.63 in their Nasdaq debut on Friday.The stock opened at $15.75 and reached $16 before trading as low as $15.25.The company priced its upsized initial public offering of 9.375 million common shares at $16 each, raising $150 million in gross proceeds.The underwriters were granted a 30-day option to buy up to an additional 1.4 million shares.The offering is expected to close Monday.Price: $15.63, Change: $-0.37, Percent Change: -2.31%
$BLSM
